IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Department of Justice (DOJ),

and

WILLIAM ALTON CLAY,
individually and in his capacity as executor of the Estate of Eugenia Clay Head,

and

PALANTIR TECHNOLOGIES INC.,
a private defense contractor headquartered in Denver, Colorado,

and

JOHN DOE CONTRACTING AGENCIES AND AFFILIATES,
whose names and identities are presently unknown,

and

AMAZON.COM, INC.,
a multinational e-commerce corporation headquartered in Seattle, Washington,

and

REV.COM, INC.,
a transcription and captioning services company headquartered in Austin, Texas,

and

PAPERBOY MARKETING,
a flyer distribution company operating in the Twin Cities under successive ownership during the period of Plaintiff’s employment,

and

ELLIE FAMILY SERVICES, n/k/a ELLIE MENTAL HEALTH, a private mental health services corporation headquartered in Mendota Heights, Minnesota,
  Defendants.

⸻

PLAINTIFF’S [__]TH SET OF DISCOVERY REQUESTS TO DEFENDANT PALANTIR TECHNOLOGIES INC.

Plaintiff: Kellyn Clay
Defendant: Palantir Technologies Inc.
Subject Matter: Exclusive Contact Lens Use as Basis for Anomaly Classification, Monitoring, Attrition, or Service Denial

⸻

Interrogatory No. 1: Identify all Palantir datasets, anomaly tags, or analytic models that classify individuals by vision correction method, including exclusive contact lens use. For each dataset or model, provide the dataset name, date of ingestion, and purpose.

Interrogatory No. 2: Describe all records Palantir maintains concerning Plaintiff’s exclusive contact lens use, including the source of the data, the method of ingestion, and the fields or variables in which it was stored.

Interrogatory No. 3: Identify all Palantir anomaly detection models in which exclusive contact lens use was used as an input variable or classification factor, and state the rationale for its inclusion.

Interrogatory No. 4: Identify all Palantir clients who received dashboards, anomaly tags, or reports in which Plaintiff’s exclusive contact lens use was included as a factor in classification. For each client, provide the name, date, and description of the deliverable.

Interrogatory No. 5: State whether Palantir has linked Plaintiff’s exclusive contact lens use to monitoring, attrition, or denial of services, and if so, describe in detail the context, dates, and decision-making processes involved.

Interrogatory No. 6: Identify all Palantir personnel, contractors, or accounts who accessed or analyzed records concerning Plaintiff’s exclusive contact lens use.

Interrogatory No. 7: Identify all internal reviews, audits, compliance assessments, or ethics analyses Palantir has conducted regarding the use of vision correction traits, including exclusive contact lens use, in anomaly detection.

Interrogatory No. 8: If Palantir denies that exclusive contact lens use was ever treated as an anomaly in Plaintiff’s records, describe in detail the safeguards or filters Palantir employs to ensure that statistically uncommon but non-pathological traits (such as contact lens use) are not misclassified as anomalies.
Interrogatory No. 1: Identify all Palantir datasets, anomaly tags, or analytic models that classify individuals based on vision correction methods, including exclusive contact lens use.

Interrogatory No. 9: State whether Palantir maintains records of Plaintiff’s vision correction status, including exclusive use of contact lenses, and describe how such records were stored, tagged, or analyzed.

Interrogatory No. 10: Identify all Palantir clients who received reports, dashboards, or analytic outputs in which exclusive contact lens use was included as a factor in classification or anomaly detection.

Interrogatory No. 11: Identify whether Palantir has linked exclusive contact lens use to monitoring, attrition, or denial of services, and if so, describe the rationale or model used.

Interrogatory No. 12: Identify all Palantir personnel, contractors, or clients who accessed or analyzed records concerning Plaintiff’s vision correction status.

Interrogatory No. 13: State whether Palantir has conducted any internal review or external audit concerning discriminatory or erroneous outcomes arising from anomaly tagging of exclusive contact lens use.

⸻

REQUESTS FOR PRODUCTION

RFP No. 1: Produce all Palantir records, datasets, or analytic models in which exclusive contact lens use was identified as a factor in anomaly detection or classification.

RFP No. 2: Produce all records referencing Plaintiff’s vision correction status, including anomaly tags, watchlist entries, or digital twin attributes indicating exclusive contact lens use.

RFP No. 3: Produce all communications (emails, memos, slide decks, chats) within Palantir discussing vision correction traits as predictive signals or anomaly factors.

RFP No. 4: Produce all contracts, deliverables, or client-facing outputs provided by Palantir that reference exclusive contact lens use or vision correction traits in classification models.

RFP No. 5: Produce all Palantir compliance reviews, ethics reviews, or legal analyses concerning the use of vision correction status in anomaly detection.

RFP No. 6: Produce all audit logs, custodial metadata, and access records showing Palantir account access to datasets referencing Plaintiff’s vision correction status.

⸻

REQUESTS FOR ADMISSION

RFA No. 1: Admit that Palantir maintains datasets that classify individuals based on vision correction methods, including exclusive contact lens use.

RFA No. 2: Admit that Palantir maintains records referencing Plaintiff’s exclusive use of contact lenses.

RFA No. 3: Admit that Palantir has classified exclusive contact lens use as an anomaly in one or more of its models.

RFA No. 4: Admit that Palantir provided anomaly tags, watchlist entries, or dashboards to clients in which exclusive contact lens use was a factor in classification.

RFA No. 5: Admit that Palantir has linked exclusive contact lens use to monitoring, attrition, or denial of services.

RFA No. 6: Admit that Palantir has not disclosed all records in its possession concerning Plaintiff’s classification based on exclusive contact lens use.

RFA No. 7: Admit that Palantir has not conducted adequate compliance or ethics reviews concerning the use of vision correction traits in anomaly detection.

RFA No. 8: Admit that treating Plaintiff’s exclusive contact lens use as an anomaly constitutes disability discrimination, as the practice arises directly from accommodation of medical conditions including Superior Canal Dehiscence Syndrome and trigeminal neuropathy.
